FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

A flight of pharma marketing fancy

Tools
Tags
pharmaceutical companies
pharma industry

With New York becoming yet another state to consider regulating pharmaceutical company gift-giving, it's worth considering whether such regs are likely to achieve their intended purpose.

Here's my premise: No matter how you work to restrict them, multi-billion dollar marketing concerns like the pharmas are going to find a way to peddle influence. Maybe, then, we should accept this and base pharma reforms on this premise.

Indulge in a flight of fantasy with me here.

What if, rather than competing with potentially questionable gifts, pharmas were required to jointly fund a U.S. educational pool. This pool would pay for reps to present on various drugs from multiple pharmaceutical companies.

Reps would definitely give sales pitches, and be compensated for their success, but would make the same bucks no matter which company they pitched on a given day.

Because there would be less money spent on building out competing sales forces, the reps could be paid more, which might attract clinical professionals to get involved, upping the quality of physician-rep discussion considerably.

The pool would pay for educational materials, but the materials would be conducted by a related research institute with no direct ties to the pharma industry. The institute would be funded indirectly through the pool.

Doctors could visit regional "educational centers" when they wanted to get current, and would be reimbursed for their time through the pool. Again, pharmas could put their pitches to work, but no one company would have funded the entire works.

Sure, the idea isn't practical, but in my mind, that's how things should work. This would let the pharmas spend all they want on promotions, but take some of the undue influence out of the process.

What do you think, folks. Is this a pipe dream, a possibility or something which could actually work? - Anne

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

You are obviously not in sales. What incentive would you have to pitch any drug on any given day? How could you build any expertise on a product or feel any ownership? Silly. I work for no specific company but here is the pitch. No competition? Come on, you been drinking some strange brew. Have you heard of CME programs and medical liaisons (clinical professionals that are not compensated based on sales)? The one thing you did get right is that - the idea isn't practical!

So you are going to ask big pharma to basically operate in a non-competitive environment driven by the reps given desires. A rep could certainly favor a variety of products. What is going to drive that favoritism? The best actual product in their mind? Who is that you would imagine is going to go for the idea of the same rep selling products that compete in the same disease state? If your premise assumes the reps would only sell a product in a disease state to eliminate that dilemma, but would rather sell a product across multiple disease states, you are now asking for a significant level of understanding, education, and commitment. Probably some sort of special certification. Who would qualify? Who would want to, at that point push the pills, with that type of education, they should probably become a doctor. This is about big business like in any other industry it is about competition. I am sick and tired of people harping on the pharma industry because of the indulgences feted on MDs. Whether it is pens or trips. Yes some of it is out of line, but what is the goal of big business. They are after all about maximizing profits. Your idea isnt going to enable this the the greatest degree. With the time constraints as they stand now, on MDs, who is going to pop into the educational center? Big pharma appreciates the knowledge and relationships that territory based reps have that split the hairs to get the scripts for them.

It's business. And having reps who choose which product too push at a given moment are not going to, from Big Pharma's perspective, serve there best interests at all times.

Your utopian ideal is certainly a flight of fancy.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.